TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
NTRA

Natera Inc

Healthcare · Diagnostics & Research

390.90$ +5.5% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement NTRA
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
49.2% 59.3% 62.5% 66.2% 64.4% 58.0% 52.1% 50.9% 55.6% 54.5% 39.7% 35.2%
50.8% 40.7% 37.5% 33.8% 35.6% 42.0% 47.9% 49.1% 44.4% 45.5% 60.3% 64.8%
10.9% 14.6% 19.3% 23.7% 19.9% 17.0% 25.6% 42.2% 38.6% 29.6% 23.8% 27.1%
38.8% 57.6% 62.7% 73.6% 60.1% 68.2% 77.7% 81.7% 71.8% 57.1% 49.6% 51.0%
50.4% 72.2% 82.0% 97.4% 80.0% 80.4% 103.2% 123.9% 110.3% 86.7% 73.4% 78.3%
0.4% -31.4% -44.4% -63.5% -44.5% -38.5% -55.3% -74.8% -66.0% -41.2% -13.1% -13.4%
2.6% 1.8% 0.2% 2.0% 4.1% 3.5% 3.9% 1.3% 1.1% 1.2% 0.6% 0.2%
-3.2% -36.9% -44.1% -64.4% -49.6% -40.6% -58.7% -75.3% -66.7% -40.1% -11.2% -11.6%
1.6% -5.2% 0.1% 0.2% 0.1% 0.7% 0.0% 0.1% 0.1% 0.0% 0.0% -2.6%
-3.2% -36.9% -44.1% -64.6% -49.7% -41.3% -58.8% -75.4% -66.8% -40.2% -11.2% -9.0%
2.6% -32.2% -43.0% -59.6% -41.6% -34.5% -52.7% -72.2% -61.8% -35.4% -8.7% -9.6%

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?